VIRConferencebusinesswire

Vir Biotechnology to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Sentiment:Negative (20)

Summary

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9 at 1:05 p.m. PT / 4:05 p.m. ET in New York, New York. A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website and will be archi

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 25, 2025 by businesswire